United States · FDA National Drug Code directory
Alprazolam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67544-414_51152b89-539c-4c80-bb84-d7f2dc082953
- Product NDC
- 67544-414
- Form
- TABLET
- Composition / generic term
- alprazolam
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 19811016
- Source listing expiry
- 20261231
Source-listed ingredients
- ALPRAZOLAM — .25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE (67544-414-15) · 67544-414-15
- 30 TABLET in 1 BOTTLE (67544-414-30) · 67544-414-30
- 45 TABLET in 1 BOTTLE (67544-414-45) · 67544-414-45
- 60 TABLET in 1 BOTTLE (67544-414-53) · 67544-414-53
- 90 TABLET in 1 BOTTLE (67544-414-60) · 67544-414-60
- 120 TABLET in 1 BOTTLE (67544-414-70) · 67544-414-70
- 180 TABLET in 1 BOTTLE (67544-414-80) · 67544-414-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →